Ironwood Pharma (IRWD) Tops Q3 EPS by 2c; Initiates Phase III Trial of 72 mcg Linaclotide

Go back to Ironwood Pharma (IRWD) Tops Q3 EPS by 2c; Initiates Phase III Trial of 72 mcg Linaclotide

Form 8-K IRONWOOD PHARMACEUTICALS For: Nov 04

November 4, 2014 4:18 PM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,D.C. 20549

... More